Addiction Medicine

The neural signature of methylphenidate-enhanced memory disruption in human drug addiction: a randomized clinical trial
Ahmet O. Ceceli, Sarah G. King, K. Rachel Drury, Natalie McClain, John Gray, Priyanthi S. Dassanayake, Jeffrey H. Newcorn, Daniela Schiller, Nelly Alia-Klein, Rita Z. Goldstein

medRxiv 2025.04.29.25326658; doi: https://doi.org/10.1101/2025.04.29.25326658

Add to Selected Citations
Physiological and perceptual effects of GLP-1 receptor agonists during alcohol consumption in people with obesity: a pilot study
Fatima Quddos, Mary Fowler, Ana Carolina de Lima Bovo, Zacarya Elbash, Allison N. Tegge, Kirstin M. Gatchalian, Anita S. Kablinger, Alexandra G. DiFeliceantonio, Warren K. Bickel

medRxiv 2025.04.25.25326413; doi: https://doi.org/10.1101/2025.04.25.25326413

Add to Selected Citations
Genetic influences for distinct impulsivity domains are differentially associated with early substance use initiation: Results from the ABCD Study
Ethan Kinstler, Aaron J. Gorelik, Sarah E. Paul, Adamya Aggarwal, Emma C. Johnson, Melissa A. Cyders, Arpana Agrawal, Ryan Bogdan, Alex P. Miller

medRxiv 2025.04.14.25325687; doi: https://doi.org/10.1101/2025.04.14.25325687

Add to Selected Citations
A Brick to a Bundle: Does Xylazine Paradoxically Contribute to Treatment-seeking and Reduced Fentanyl Use?
Adams L. Sibley, Colin W. Miller, Elizabeth Joniak-Grant, Alice Bell, Malcolm Visnich, Steve Alsum, Nabarun Dasgupta

medRxiv 2025.04.11.25325471; doi: https://doi.org/10.1101/2025.04.11.25325471

Add to Selected Citations
Reduced Plasma IL-40 and Total IgA Levels in Patients with Substance Use Disorders: Indicators of Impaired Humoral Immune Response
Sheu Kadiri Rahamon, Abdulrahamon Adebayo Sikirullah, Sofiyat Opeyemi Bello, Oluremi Oladele, Victor Olufolahan Lasebikan

medRxiv 2025.04.10.25325594; doi: https://doi.org/10.1101/2025.04.10.25325594

Add to Selected Citations
Psychedelics as pharmacotherapeutics for substance use disorders: a scoping review on clinical trials and perspectives on underlying neurobiology
Lucas Wittenkeller, Gary Gudelsky, John T. Winhusen, Davide Amato

medRxiv 2025.04.04.25324315; doi: https://doi.org/10.1101/2025.04.04.25324315

Add to Selected Citations
The development of a national bilingual cross-sectional questionnaire on attitudes towards supervised consumption sites and e-health overdose response interventions in Canada: The Canadian National Questionnaire on Overdose Monitoring (CNQOM)
N. Rider, B. Seo, D. Viste, W. Rioux, N. Sedaghat, B. Pan, Y.N. Al Hamarneh, G.R. McCormack, F. Aghajafari, L. McDougall, S. M. Ghosh

medRxiv 2025.03.27.25324132; doi: https://doi.org/10.1101/2025.03.27.25324132

Add to Selected Citations
Unravelling Polygenic Risk and Environmental Interactions in Adolescent Polysubstance Use: a U.S. Population-Based Observational Study
Dongmei Zhi, Brandon T. Sanzo, Daniel H. Jung, Judit Cabana-Domínguez, Noelia Fernàndez-Castillo, Bru Cormand, Jing Sui, Rongtao Jiang, 23andMe Research Team, Eden A. Evins, Scott E. Hadland, Joshua L. Roffman, Richard T. Liu, Jodi Gilman, Phil H. Lee

medRxiv 2025.03.21.25324407; doi: https://doi.org/10.1101/2025.03.21.25324407

Add to Selected Citations
Theta Burst Stimulation in Patients With Methamphetamine Use Disorder: A Meta-Analysis and Systematic Review
Gopalkumar Rakesh, Thomas G. Adams, Dylan H. Ballard, Christopher J. McLouth, Craig R. Rush

medRxiv 2025.03.24.25324326; doi: https://doi.org/10.1101/2025.03.24.25324326

Add to Selected Citations
Subjective Response to Opioids Predicts Risk for Opioid Use Disorder
Jean Gonzalez, Vinh Tran, John Meredith, Ivonne Xu, Ritviksiddha Penchala, Laura Vilar-Ribó, Natasia Courchesne-Krak, Daniel Zoleikhaeian, 23andMe Research Team, Matthew McIntyre, Pierre Fontanillas, Katelyn Kukar Bond, Eric O. Johnson, Alvin Jeffery, James MacKillop, Carla Marienfeld, Harriet de Wit, Abraham A. Palmer, Sandra Sanchez-Roige

medRxiv 2025.03.21.25324409; doi: https://doi.org/10.1101/2025.03.21.25324409

Add to Selected Citations

Addiction Medicine

Pages